Carlsmed (NASDAQ:CARL) used its presentation at Needham’s 25th Annual Healthcare Conference to highlight progress in its ...

ProMIS Neurosciences, Inc. (NASDAQ: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other neurodegenerative disorders, today ...

Detailed price information for Healwell AI Inc A Sub Vtg (HWAIF) from The Globe and Mail including charting and trades.

Travere Therapeutics, Inc. ( TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS April 13, 2026 6:45 PM EDT ...

According to GLOBOCAN 2022, Vietnam records approximately 180,000 new cancer cases and over 120,000 deaths annually.

Seven abstracts represent data across migraine, childhood-onset epilepsy and multiple system atrophy (MSA), highlighting Lundbeck's biology-driven approach to developing treatments for serious brain ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2025, on Wednesday, ...

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, ...

The castration-sensitive prostate cancer market presents opportunities driven by rising prostate cancer incidences, an aging population, growing awareness, and improved early diagnosis. Successive ...

MD+DI Senior Editor Amanda Pedersen highlights FDA's use of a chief medical officer's name in a recent warning letter to ExThera for unapproved claims.

Physician and seasoned life sciences investor with more than two decades of experience across clinical practice, ...

Effective emergency preparedness and response require all senior living employees to have a constant mindset and posture of readiness.